Characterization of anti-2-phenyloxazolone Fab fragments produced in Escherichia coli

Kaija Alfthan; Kristiina Takkinen; Dorothea Sizmann; Tiina Immonen; Liisa Vanne; Marja-Leena Laukkanen; Sirkka Keränen; Ilkka Seppälä; Matti Kaartinen; Jonathan Knowles; Tuula Teeri

Characterization of anti-2-phenyloxazolone Fab fragments produced in Escherichia coli

Kaija Alfthan, Kristiina Takkinen, Dorothea Sizmann, Tiina Immonen, Liisa Vanne, Marja-Leena Laukkanen, Sirkka Keränen, Ilkka Seppälä, Matti Kaartinen, Jonathan Knowles, Tuula Teeri

Research output: Contribution to conference › Conference Abstract › Scientific

Original language	English
Publication status	Published - 1991
MoE publication type	Not Eligible
Event	2nd Annual IBC International Conference Antibody Engineering - San Diego, United States Duration: 18 Dec 1991 → 18 Dec 1991

Conference

Conference	2nd Annual IBC International Conference Antibody Engineering
Country/Territory	United States
City	San Diego
Period	18/12/91 → 18/12/91

Cite this

@conference{9e678f931958446993a874a32aaffab6,

title = "Characterization of anti-2-phenyloxazolone Fab fragments produced in Escherichia coli",

author = "Kaija Alfthan and Kristiina Takkinen and Dorothea Sizmann and Tiina Immonen and Liisa Vanne and Marja-Leena Laukkanen and Sirkka Ker{\"a}nen and Ilkka Sepp{\"a}l{\"a} and Matti Kaartinen and Jonathan Knowles and Tuula Teeri",

note = "Project code: BIO8015; 2nd Annual IBC International Conference Antibody Engineering ; Conference date: 18-12-1991 Through 18-12-1991",

year = "1991",

language = "English",

}

TY - CONF

T1 - Characterization of anti-2-phenyloxazolone Fab fragments produced in Escherichia coli

AU - Alfthan, Kaija

AU - Takkinen, Kristiina

AU - Sizmann, Dorothea

AU - Immonen, Tiina

AU - Vanne, Liisa

AU - Laukkanen, Marja-Leena

AU - Keränen, Sirkka

AU - Seppälä, Ilkka

AU - Kaartinen, Matti

AU - Knowles, Jonathan

AU - Teeri, Tuula

N1 - Project code: BIO8015

PY - 1991

Y1 - 1991

M3 - Conference Abstract

T2 - 2nd Annual IBC International Conference Antibody Engineering

Y2 - 18 December 1991 through 18 December 1991

ER -